These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Benign lymphoproliferation syndrome, autoimmune neutropenia and thrombocytopenia in partial Di George syndrome: efficacy of rh G-CSF and prednisone. Martire B; Burattini MG; De Santis A; Schettini F; De Mattia D Acta Paediatr; 2001 Jul; 90(7):821-3. PubMed ID: 11519990 [No Abstract] [Full Text] [Related]
46. Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato-oncological patients: randomized controlled trial. Paul M; Ram R; Kugler E; Farbman L; Peck A; Leibovici L; Lahav M; Yeshurun M; Shpilberg O; Herscovici C; Wolach O; Itchaki G; Bar-Natan M; Vidal L; Gafter-Gvili A; Raanani P Am J Hematol; 2014 Mar; 89(3):243-8. PubMed ID: 24178750 [TBL] [Abstract][Full Text] [Related]
47. Therapy with granulocyte colony-stimulating factor in systemic lupus erythematosus may be associated with severe flares. Vasiliu IM; Petri MA; Baer AN J Rheumatol; 2006 Sep; 33(9):1878-80. PubMed ID: 16832843 [TBL] [Abstract][Full Text] [Related]
48. Quality of life of patients with severe chronic neutropenia receiving long-term treatment with granulocyte colony-stimulating factor. Jones EA; Bolyard AA; Dale DC JAMA; 1993 Sep; 270(9):1132-3. PubMed ID: 7688828 [TBL] [Abstract][Full Text] [Related]
49. Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factor. Katoh M; Shikoshi K; Takada M; Umeda M; Tsukahara T; Kitagawa S; Shirai T Ann Hematol; 1993 Oct; 67(4):201-2. PubMed ID: 7692983 [No Abstract] [Full Text] [Related]
51. The use of G-CSF during craniospinal irradiation. Marks LB; Halperin EC Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):905-6; discussion 907. PubMed ID: 7688363 [No Abstract] [Full Text] [Related]
52. Prevention and management of neutropenic sepsis in patients with cancer: summary of NICE guidance. Phillips R; Hancock B; Graham J; Bromham N; Jin H; Berendse S BMJ; 2012 Sep; 345():e5368. PubMed ID: 22993392 [No Abstract] [Full Text] [Related]
53. Cyclic and chronic neutropenia: an update on diagnosis and treatment. Dale DC Clin Adv Hematol Oncol; 2011 Nov; 9(11):868-9. PubMed ID: 22252620 [No Abstract] [Full Text] [Related]
54. Flare of psoriasis and psoriatic arthritis following treatment with granulocyte colony-stimulating factor. Kavanaugh A Am J Med; 1996 Nov; 101(5):567-8. PubMed ID: 8948284 [No Abstract] [Full Text] [Related]
55. G-CSF: early benefits but late risks? Falkenburg JH Blood; 2001 Apr; 97(8):2194. PubMed ID: 11290577 [No Abstract] [Full Text] [Related]
56. ELANE gene mutation-induced cyclic neutropenia manifesting as recurrent fever with oral mucosal ulcer: A case report. Chen X; Peng W; Zhang Z; Wu Y; Xu J; Zhou Y; Chen L Medicine (Baltimore); 2018 Mar; 97(10):e0031. PubMed ID: 29517659 [TBL] [Abstract][Full Text] [Related]
57. New insights into the pathomechanism of cyclic neutropenia. Mir P; Klimiankou M; Findik B; Hähnel K; Mellor-Heineke S; Zeidler C; Skokowa J; Welte K Ann N Y Acad Sci; 2020 Apr; 1466(1):83-92. PubMed ID: 32083314 [TBL] [Abstract][Full Text] [Related]
58. Differential transcriptional control of hematopoiesis in congenital and cyclic neutropenia patients harboring Zeidler A; Borbaran-Bravo N; Dannenmann B; Ritter M; Nasri M; Klimiankou M; Kandabarau S; Zahabi A; König J; Zeidler C; Skokowa J; Welte K Haematologica; 2024 May; 109(5):1393-1402. PubMed ID: 37855057 [TBL] [Abstract][Full Text] [Related]